![Tuomas Tenkanen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tuomas Tenkanen
Algemeen Directeur bij Mobidiag Oy
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Johan Edvard Lundin | M | 60 | 11 jaar | |
Jukka Pekka Tapaninen | M | 61 | 9 jaar | |
Pekka Allan Antero Mattila | M | 65 | 11 jaar | |
Kaisa Helminen | F | 49 | 10 jaar | |
Rabbe Ilari Klemets | M | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Nils-Göran Pettersson | M | 79 |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Hannu Tapani Syrjälä | M | 58 |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | 7 jaar |
Jean de Gunzburg | M | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Feng Chaojie | F | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Joe Bernardo | M | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Toumas Ropponen | M | 46 | 7 jaar | |
Stuart Cranmer | M | - |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Mikael Edvard Lundin | M | 56 | - | |
Kari Pekka Pitkänen | M | 64 | 10 jaar | |
Timo Juhani Soininen | M | 59 | 6 jaar | |
Mikael Jääskeläinen | M | - | - | |
Antti Merivirta | M | - | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Finland | 17 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tuomas Tenkanen
- Persoonlijk netwerk